View all news

EPSRC funding for development of novel antimicrobial wound dressings

12 February 2014

A team lead by Dr Michele Barbour, Senior Lecturer in Biomaterials, has been awarded EPSRC Impact Acceleration funding to develop wound dressings incorporating novel antimicrobial nanoparticles.

A team lead by Dr Michele Barbour, Senior Lecturer in Biomaterials, has been awarded EPSRC Impact Acceleration funding to develop wound dressings incorporating novel antimicrobial nanoparticles. The nanoparticles, which were developed in the School and patented by the University in 2013, will be incorporated into wound dressings used to protect entry sites for venous catheters.

The team comprises researchers in biomaterials science, nanoscience, clinical oncology, wound healing and nanotoxicology at Bristol and a microbiology collaborator based at Cardiff Metropolitan University. Michele said “We’re very excited about this new project. Catheter entry site dressings in current use can act as reservoirs for bacteria, and even those which offer antimicrobial protection only remain effective for a few days, but dressings often remain in place for 7 days. We hope that our dressings will ultimately be able to protect patients from catheter-related infections for at least this long.”

Edit this page